RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Ciglitazone is a member of the thiazolidinedione family, and specifically binds to peroxisome proliferator-activated receptor-γ (PPARγ), thereby promoting adipocyte differentiation. We hypothesized that ciglitazone as a PPARγ ligand in the absence of an adipocyte differentiation cocktail would increase adiponectin and adipogenic gene expression in bovine satellite cells (BSC). Muscle-derived BSCs were isolated from six, 18-month-old Yanbian Yellow Cattle. The BSC were cultured for 96 h in differentiation medium containing 5 μM ciglitazone (CL), 10 μM ciglitazone (CM), or 20 μM ciglitazone (CH). Control (CON) BSC were cultured only in a differentiation medium (containing 2% horse serum). The presence of myogenin, desmin, and paired box 7 (Pax7) proteins was confirmed in the BSC by immunofluorescence staining. The CL, CM, and CH treatments produced higher concentrations of triacylglycerol and lipid droplet accumulation in myotubes than those of the CON treatment. Ciglitazone treatments significantly increased the relative expression of PPARγ, CCAAT/enhancer-binding protein alpha (C/EBPα), C/EBPβ, fatty acid synthase, stearoyl-CoA desaturase, and perilipin 2. Ciglitazone treatments increased gene expression of Pax3 and Pax7 and decreased expression of myogenic differentiation-1, myogenin, myogenic regulatory factor-5, and myogenin-4 (p < 0.01). Adiponectin concentration caused by ciglitazone treatments was significantly greater than CON (p < 0.01). RNA sequencing showed that 281 differentially expressed genes (DEGs) were found in the treatments of ciglitazone. DEGs gene ontology (GO) analysis showed that the top 10 GO enrichment significantly changed the biological processes such as protein trimerization, negative regulation of cell proliferation, adipocytes differentiation, and cellular response to external stimulus. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that DEGs were involved in the p53 signaling pathway, PPAR signaling pathway, biosynthesis of amino acids, tumor necrosis factor signaling pathway, non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, and Wnt signaling pathway. These results indicate that ciglitazone acts as PPARγ agonist, effectively increases the adiponectin concentration and adipogenic gene expression, and stimulates the conversion of BSC to adipocyte-like cells in the absence of adipocyte differentiation cocktail.

참고문헌 (Reference)

1 Tyler C Prestwich, "Wnt/β-catenin signaling in adipogenesis and metabolism" Elsevier BV 19 (19): 612-617, 2007

2 G. Cossu, "Wnt signaling and the activation of myogenesis in mammals" Wiley 18 (18): 6867-6872, 1999

3 Yiyang Yue, "Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy" Elsevier BV 133 : 124-130, 2017

4 Erine H. Budi, "Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility" Elsevier BV 27 (27): 658-672, 2017

5 N. K. Singh, "Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone1" Oxford University Press (OUP) 85 (85): 1126-1135, 2007

6 E. Hu, "Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha" Proceedings of the National Academy of Sciences 92 (92): 9856-9860, 1995

7 Lydia Teboul, "Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells" Elsevier BV 270 (270): 28183-28187, 1995

8 Xia Yi, "The whole transcriptional profiling of cellular metabolism during adipogenesis from hMSCs" Wiley 235 (235): 349-363, 2020

9 Wan-Chun Li, "The molecular basis of transdifferentiation" Wiley 9 (9): 569-582, 2005

10 Antonio Fabregat, "The Reactome Pathway Knowledgebase" Oxford University Press (OUP) 46 (46): D649-D655, 2018